Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
SYHA1801
/
CSPC Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
SYHA1801
/
CSPC Pharma
Enrollment open, Monotherapy, Metastases:
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors
(clinicaltrials.gov) - May 7, 2020
P1
, N=186, Recruiting,
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting --> Recruiting
|||
|||||||
SYHA1801
/
CSPC Pharma
New P1 trial, Monotherapy, Metastases:
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors
(clinicaltrials.gov) - Mar 16, 2020
P1
, N=186, Not yet recruiting,
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.